Peer-reviewedCC BYGenes
DNA Methylation Alterations in Patients with Moderate-to-Severe Thyroid Eye Disease Treated with Intravenous Glucocorticoids
- 1Department of Internal Medicine and Endocrinology, Medical University of Warsaw, 02-097 Warsaw, Poland; (A.K.); (T.B.)
- 2Department of Medical Genetics, Centre for Biostructure, Medical University of Warsaw, 02-106 Warsaw, Poland; (P.G.); (G.K.); (R.P.)
Related
- DNA Methylation and TMPRSS2-ERG Fusion Status in Patients with Prostate Cancer from The Republic of North Macedonia
- Inflammatory Bowel Disease Patients’ Acceptance for Switching from Intravenous Infliximab or Vedolizumab to Subcutaneous Formulation: The Nancy Experience
- Economic and organizational impact of oral versus intravenous and subcutaneous administration of hypomethylating agents in patients with acute myeloid leukemia not eligible for intensive chemotherapy in Spain
- Safety and tolerability of anti-toll-like receptor 3, monoclonal antibody PRV-300 in patients with moderate-to-severe ulcerative colitis: a randomized phase 1B clinical trial (PULSE).
- Functional alterations of neutrophils from β-thalassemia patients exposed to Pythium insidiosum: An ex vivo study
BibTeX
@article{radziszewski2026methylation,
title = {{DNA Methylation Alterations in Patients with Moderate-to-Severe Thyroid Eye Disease Treated with Intravenous Glucocorticoids}},
author = {Mikołaj Radziszewski and Piotr Gasperowicz and Aleksander Kuś and Grażyna Kostrzewa and Rafał Płoski and Tomasz Bednarczuk},
journal = {Genes},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13704200},
note = {CC BY},
}
RIS
TY - JOUR
TI - DNA Methylation Alterations in Patients with Moderate-to-Severe Thyroid Eye Disease Treated with Intravenous Glucocorticoids
AU - Mikołaj Radziszewski
AU - Piotr Gasperowicz
AU - Aleksander Kuś
AU - Grażyna Kostrzewa
AU - Rafał Płoski
AU - Tomasz Bednarczuk
PY - 2026
DA - 2026/09/24
JO - Genes
UR - https://europepmc.org/article/PMC/PMC13704200
SN - 2073-4425
ER -